Actively Recruiting

Age: 18Years +
All Genders
ID05620329

University of North Carolina Pleural Fluid Registry for Lung Cancer, Breast Cancer, and Lung Infection

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-10-16

9999

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting biospecimens such as blood, tissue, or body fluids from patients with known or suspected lung cancer, breast cancer, or lung infections. The study aims to create a pleural fluid registry that can be used in future research to better understand diseases, improve tests, and develop new treatments. This observational study is sponsored by the UNC Lineberger Comprehensive Cancer Center and focuses on patients with pleural fluid buildup related to these conditions. Participants include both inpatients and outpatients who have pleural fluid requiring clinically indicated drainage due to infection or malignancy. The registry will gather samples and data over a long period, with the primary outcome being the creation of this pleural fluid registry, planned to last 32 years. No specific treatments or interventions are assigned, as this is an observational study. During the study, participant involvement includes undergoing pleural fluid drainage as part of their clinical care. Researchers will collect and store the pleural fluid and other related biospecimens for future study. There are no additional treatments or experimental procedures, and participant safety is monitored through standard clinical care. The total participation duration varies depending on each patient's clinical situation and ongoing data collection over the study period.

CONDITIONS

Brief Title

UNC Pleural Fluid Registry

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who are 18 years or older
  • Inpatients and outpatients
  • Diagnosed with pleural fluid and referred for clinically indicated drainage
  • Clinical evidence of pulmonary infection with effusion or malignancy
Not Eligible

You will not qualify if you...

  • Medical conditions that prevent safe pleural fluid drainage as determined by the doctor
  • Incarcerated individuals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Sample Collection

Duration - Up to 32 years

Participants provide pleural fluid samples as part of the registry collection.

1 to 2 visits depending on clinical indication

Trial Site Locations

Total: 1 location

1

UNC Lingeberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

Loading map...

Research Team

C

Carmmen Garcia

L

Luz Cuaboy

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here